// App-Quantinova.ai

e21225 : Association between efficacy of immunotherapy and rate of cancer progression at the time of initiation of immunotherapy: An analysis in metastatic non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Thiru Prasanna

Principal Investigators

  • Malmaruha Arasaratnam

  • Adnan Nagrial

  • Catriona M. McNeil

  • Rebecca Asher

  • Megan Barnet

  • Michael J. Boyer

  • Steven Chuan-Hao Kao

Medical Centers

  • Chris O'Brien Lifehouse, Camperdown, Australia

  • Westmead Hospital, Westmead, Australia

  • The Kinghorn Cancer Centre, Sydney, Australia

  • Chris O'Brien Lifehouse, Camperdown, Australia

  • NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • Chris O'Brien Lifehouse, Sydney, Australia

  • Chris O'Brien Lifehouse, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved